Literature DB >> 6979381

Chemotherapy of a malignant, metastasizing giant-cell tumor of bone: report of an unusual case and the response to combination chemotherapy.

O Mella, O Dahl, G Bang, H Engedal, J Gøthlin, O D Lunde.   

Abstract

A 13-year-old girl was treated surgically for a giant-cell tumor of bone originating in the talus and for a recurrence in the distal tibia. She later developed liver and lung metastases and was treated for two years, five months with a combination of vincristine, doxorubicin, cyclophosphamide and actinomycin-D, and thereafter with high-dose methotrexate/vincristine with citrovorum factor rescue. A good response was obtained and the patient is without evidence of disease 12 months after a salvage thoracotomy for residual disease in the left lung. Aspects of this singular case are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979381     DOI: 10.1002/1097-0142(19820715)50:2<207::aid-cncr2820500206>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Multicentric Giant Cell Tumor of Bone: Metachronous Presentation-a Case Report.

Authors:  Nur Asma Sapiai; W S Wan Fatihah; W I Faisham; M Z Anani Aila
Journal:  Indian J Surg Oncol       Date:  2021-05-17

Review 2.  Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.

Authors:  Vittoria Colia; Salvatore Provenzano; Nadia Hindi; Paolo G Casali; Silvia Stacchiotti
Journal:  Rep Pract Oncol Radiother       Date:  2016-01-13

Review 3.  Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone.

Authors:  Czar Louie Gaston; Robert J Grimer; Michael Parry; Silvia Stacchiotti; Angelo Paolo Dei Tos; Hans Gelderblom; Stefano Ferrari; Giacomo G Baldi; Robin L Jones; Sant Chawla; Paolo Casali; Axel LeCesne; Jean-Yves Blay; Sander P D Dijkstra; David M Thomas; Piotr Rutkowski
Journal:  Clin Sarcoma Res       Date:  2016-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.